Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients

ATASOY, BESTE; DANE, FAYSAL; Cetin, I.; Ozgen, Z.; Kefeli, AYŞEGÜL; Ibrahimov, R.; Turhal, N.; Abacioglu, U.; Turkeri, L.

doi:10.1007/s12094-013-1047-8

Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients

Atıf İçin Kopyala

ATASOY B. M., DANE F., Cetin I. A., Ozgen Z., Kefeli A., Ibrahimov R., ...Daha Fazla

CLINICAL & TRANSLATIONAL ONCOLOGY, cilt.16, sa.1, ss.91-95, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 16 Sayı: 1
Basım Tarihi: 2014
Doi Numarası: 10.1007/s12094-013-1047-8
Dergi Adı: CLINICAL & TRANSLATIONAL ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.91-95
Anahtar Kelimeler: Bladder cancer, Concurrent gemcitabine, Medically unfit patients, Radiotherapy, COMBINED-MODALITY PROGRAM, RADIATION-THERAPY, PHASE-I, NEOADJUVANT CHEMOTHERAPY, ORGAN PRESERVATION, RADIOTHERAPY, TRIAL, CISPLATIN
Kocaeli Üniversitesi Adresli: Hayır

Özet

We aimed to determine the efficacy and the toxicity of low dose weekly gemcitabine with radiation therapy in medically unfit muscle-invasive bladder cancer patients.